International Stem Cell Corp. (ISCO)

[236T568]

so......of the three business areas that produce revenues, only ONE, the lower margined Reagent product line, is the only one that had increased revenues...

and say, why don't you tell us what ISCO has done in replacing the CFO that resigned almost a year ago, the 3rd CFO in the last 5 years?

oops, you can't because the Russian girl that is the General Counsel for ISCO is now also the Principal Financial Officer

So it appears that no one wants to work for ISCO that would involve being responsible for its financial statements filed with the SEC. What does that tell you about what is going on with this Russian controlled company?

Looks like a good year end report to me. I don't see any reason for negativity. Sad that it seems that is all some wish to see and hear these days. Kudos to ISCO for a good year end report and the exchange upgrade. If the subs continue to improve, they alone are worth today's capitalization and more. Oh well, go figure, still flying too low under the radars I guess.